Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Stopped early · Phase 2

Conditions studied: Parkinson's Disease With Motor Fluctuations

In brief

The purpose of this study is to evaluate the long term safety and tolerability of PF-06649751 in Parkinson's disease patients who experience motor-fluctuations.

Key facts

Study ID

NCT03185481

Run by

Pfizer

People needed

5

Starts

2017-07-06

Expected to finish

2017-10-25

Last updated by the study team

2019-04-12

Who can join

Age: 40 and older, up to 87. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Having successfully completed parent study B7601003.
• Clinical diagnosis of Parkinson's disease.
• Able to refrain from any Parkinson's disease medication not permitted by the protocol.

You may not qualify if…

• Female of childbearing potential.
• Severe acute or chronic medical or psychiatric condition or laboratory abnormality.
• Participation in other studies involving investigational drug(s), or treatment with any investigational drug within 30 days.

Where it is running

• Hoag Memorial Hospital Presbyterian — Newport Beach, California, United States
• Associated Neurologists of Southern CT, PC — Fairfield, Connecticut, United States
• Parkinson's Disease and Movement Disorders Center of Boca Raton — Boca Raton, Florida, United States
• Atlanta Center for Medical Research — Atlanta, Georgia, United States
• Pharmaceutical Research Associates, Inc. — Marlton, New Jersey, United States
• University of Toledo, Gardner-McMaster Parkinson Center — Toledo, Ohio, United States
• University of Toledo, Investigational Drug Services — Toledo, Ohio, United States
• The Movement Disorder Clinic of Oklahoma — Tulsa, Oklahoma, United States
• Booth Gardner Parkinson's Care Center — Kirkland, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.